Alovudine

Alovudine was an antiviral agent being developed by Medivir, which was discontinued after a Phase II trial in 2005 due to toxicity. It was a DNA polymerase inhibitor.

Alovudine

Alovudine was an antiviral agent being developed by Medivir, which was discontinued after a Phase II trial in 2005 due to toxicity. It was a DNA polymerase inhibitor.